384 related articles for article (PubMed ID: 34410338)
1. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
Lu F; Li M; Min X; Li C; Zeng X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
[TBL] [Abstract][Full Text] [Related]
2. De novo generation of dual-target ligands for the treatment of SARS-CoV-2 using deep learning, virtual screening, and molecular dynamic simulations.
Humayun F; Khan F; Khan A; Alshammari A; Ji J; Farhan A; Fawad N; Alam W; Ali A; Wei DQ
J Biomol Struct Dyn; 2024 Apr; 42(6):3019-3029. PubMed ID: 37449757
[TBL] [Abstract][Full Text] [Related]
3. The power of deep learning to ligand-based novel drug discovery.
Baskin II
Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
[TBL] [Abstract][Full Text] [Related]
4. Reinforced Adversarial Neural Computer for de Novo Molecular Design.
Putin E; Asadulaev A; Ivanenkov Y; Aladinskiy V; Sanchez-Lengeling B; Aspuru-Guzik A; Zhavoronkov A
J Chem Inf Model; 2018 Jun; 58(6):1194-1204. PubMed ID: 29762023
[TBL] [Abstract][Full Text] [Related]
5. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
[TBL] [Abstract][Full Text] [Related]
6. De Novo Molecule Design by Translating from Reduced Graphs to SMILES.
Pogány P; Arad N; Genway S; Pickett SD
J Chem Inf Model; 2019 Mar; 59(3):1136-1146. PubMed ID: 30525594
[TBL] [Abstract][Full Text] [Related]
7. Generative Adversarial Networks for De Novo Molecular Design.
Lee YJ; Kahng H; Kim SB
Mol Inform; 2021 Oct; 40(10):e2100045. PubMed ID: 34622551
[TBL] [Abstract][Full Text] [Related]
8. Generative Deep Learning for Targeted Compound Design.
Sousa T; Correia J; Pereira V; Rocha M
J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
[TBL] [Abstract][Full Text] [Related]
9. Generative chemistry: drug discovery with deep learning generative models.
Bian Y; Xie XQ
J Mol Model; 2021 Feb; 27(3):71. PubMed ID: 33543405
[TBL] [Abstract][Full Text] [Related]
10. Deep reinforcement learning for de novo drug design.
Popova M; Isayev O; Tropsha A
Sci Adv; 2018 Jul; 4(7):eaap7885. PubMed ID: 30050984
[TBL] [Abstract][Full Text] [Related]
11. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
[TBL] [Abstract][Full Text] [Related]
12. Deep inverse reinforcement learning for structural evolution of small molecules.
Agyemang B; Wu WP; Addo D; Kpiebaareh MY; Nanor E; Roland Haruna C
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33348357
[TBL] [Abstract][Full Text] [Related]
13. Generative machine learning for de novo drug discovery: A systematic review.
Martinelli DD
Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
[TBL] [Abstract][Full Text] [Related]
14. Faster and more diverse de novo molecular optimization with double-loop reinforcement learning using augmented SMILES.
Bjerrum EJ; Margreitter C; Blaschke T; Kolarova S; de Castro RL
J Comput Aided Mol Des; 2023 Aug; 37(8):373-394. PubMed ID: 37329395
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive assessment of deep generative architectures for de novo drug design.
Wang M; Sun H; Wang J; Pang J; Chai X; Xu L; Li H; Cao D; Hou T
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34929743
[TBL] [Abstract][Full Text] [Related]
16.
Krishnan SR; Bung N; Vangala SR; Srinivasan R; Bulusu G; Roy A
J Chem Inf Model; 2022 Nov; 62(21):5100-5109. PubMed ID: 34792338
[TBL] [Abstract][Full Text] [Related]
17. De novo generation of hit-like molecules from gene expression signatures using artificial intelligence.
Méndez-Lucio O; Baillif B; Clevert DA; Rouquié D; Wichard J
Nat Commun; 2020 Jan; 11(1):10. PubMed ID: 31900408
[TBL] [Abstract][Full Text] [Related]
18. Generative Models for De Novo Drug Design.
Tong X; Liu X; Tan X; Li X; Jiang J; Xiong Z; Xu T; Jiang H; Qiao N; Zheng M
J Med Chem; 2021 Oct; 64(19):14011-14027. PubMed ID: 34533311
[TBL] [Abstract][Full Text] [Related]
19. De novo molecular design with deep molecular generative models for PPI inhibitors.
Wang J; Chu Y; Mao J; Jeon HN; Jin H; Zeb A; Jang Y; Cho KH; Song T; No KT
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830870
[TBL] [Abstract][Full Text] [Related]
20. UnCorrupt SMILES: a novel approach to de novo design.
Schoenmaker L; Béquignon OJM; Jespers W; van Westen GJP
J Cheminform; 2023 Feb; 15(1):22. PubMed ID: 36788579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
